arrow
M

Muhammad Badar

gomal university
H指数:33
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021

全球、区域和国家在实现世卫组织终结结核病战略的2020里程碑方面取得的进展: 对全球疾病负担研究2021的系统分析

2024-07-0111
OAAI
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

2022至2050 204个国家和地区的疾病负担情景: 全球疾病负担研究2021的预测分析

LANCET
IF88.5
2024-05-0179
OAAI
Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study

1990至2019亚洲癌症负担的时间模式: 全球疾病负担2019研究的系统检查

2024-02-018
OAAI
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

全球、区域和国家糖尿病负担1990年2021年,以及患病率2050年预测: 全球疾病负担研究的系统分析2021

LANCET
IF88.5
2023-07-01941
OAAI
Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms

旁路敏感性β-内酰胺类药物作为治疗既存耐甲氧西林金黄色葡萄球菌(MRSA)生物膜的有效疗法

2023-05-021
OAAI
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

2019年与33种细菌性病原体相关的全球死亡率:一项针对2019年全球疾病负担研究的系统性分析

LANCET
IF88.5
2022-12-01722
OAAI
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019

1990—2019年全球下呼吸道感染疾病负担及危险因素的年龄-性别差异:2019年全球疾病负担研究结果

2022-11-0193
OAAI
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019

可归因于风险因素的全球癌症负担,2010-19: 对全球疾病负担研究2019的系统分析

LANCET
IF88.5
2022-08-01418
OAAI